Author

Erika Abbott

University of Kansas Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Anup RamachandraniD· 1 shared Benjamin Leeland WoolbrightiD· 1 shared Darren P. WallaceiD· 1 shared Jephte Yao AkakpoiD· 1 shared John Arthur TayloriD· 1 shared Rick G. SchnellmanniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Anup RamachandranORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

4-Methylpyrazole-mediated inhibition of Cytochrome P450 2E1 protects renal epithelial cells, but not bladder cancer cells, from cisplatin toxicity

Jephte Yao Akakpo, Erika Abbott, Benjamin Leeland Woolbright, Anup Ramachandran, Rick G. Schnellmann, Darren P. Wallace, John Arthur Taylor

This study shows that inhibiting CYP2E1 with 4MP protects kidneys from cisplatin toxicity but does not affect cisplatin's anti-cancer effects in bladder cancer cells.

Toxicological Sciences · Apr 30, 2025Peer-reviewedPharmacology & Toxicology